Prevalence of wild‐type transthyretin amyloidosis in a prospective heart failure cohort with preserved and mildly reduced ejection fraction: Results of the Amylo‐<scp>VIP‐HF</scp> study-Reference-Cited by-同舟云学术

Prevalence of wild‐type transthyretin amyloidosis in a prospective heart failure cohort with preserved and mildly reduced ejection fraction: Results of the Amylo‐VIP‐HF study

Published:2024-03 Issue:3 Volume:26 Page:695-698
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European J of Heart Fail

Author:

Tubben Alwin¹²^ORCID,Tingen Hendrea S.A.²³,Prakken Niek H.J.⁴,van Empel Vanessa P.M.⁵,Gorter Thomas M.¹,Meems Laura M.G.¹,Manintveld Olivier C.⁶,Rienstra Michiel¹,Tieleman Robert G.¹⁷,Glaudemans Andor W.J.M.³,van Veldhuisen Dirk J.¹,Slart Riemer H.J.A.²³,Nienhuis Hans L.A.²⁸,van der Meer Peter¹²

Affiliation:

1. Department of Cardiology University Medical Centre Groningen Groningen The Netherlands

2. Amyloidosis Centre of Expertise University Medical Centre Groningen Groningen The Netherlands

3. Department of Nuclear Medicine and Molecular Imaging University Medical Centre Groningen Groningen The Netherlands

4. Department of Radiology University Medical Centre Groningen Groningen The Netherlands

5. Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM) Medical University Centre Maastricht Maastricht The Netherlands

6. Department of Cardiology Erasmus Medical Centre Rotterdam Rotterdam The Netherlands

7. Department of Cardiology Martini Hospital Groningen The Netherlands

8. Department of Internal Medicine University Medical Centre Groningen Groningen The Netherlands

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.3186

Reference12 articles.

1. Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology W orking G roup on M yocardial and P ericardial D iseases

2. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction

3. Suspicion, screening, and diagnosis of wild‐type transthyretin amyloid cardiomyopathy: a systematic literature review

4. Prevalence of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of transthyretin cardiac amyloidosis in patients with heart failure with preserved ejection fraction: the PRACTICA study;Revista Española de Cardiología (English Edition);2024-07